Along with this detailed characterization of the drug delivery system, the p53 induction and inhibition of cell proliferation following 18 h treatment of colorectal cancer HCT116p53+/+ cells with different doses of INZ-C, nanoparticle, or n-INZ-C was evaluated. Here, TP53 is linked to colorectal cancer.